Consensus Boston Scientific Corporation

Equities

BSX

US1011371077

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
67.24 USD +1.52% Intraday chart for Boston Scientific Corporation +1.69% +16.31%

Evolution of the average Target Price on Boston Scientific Corporation

Price target over the last 5 years

History of analyst recommendation changes

45efa017bbff7d14e7cb74101.eEmmHaSqvRRmnZKNZ5XEHP1TjhStYUy3yUZAs0s2Bv0.FhDJbePO_HA31KK_AfLzL4k56HrVJC3c-yUHyQpOdoouMO5N_u3RXCXW8Q~6eb41930432d2aef02ab902dbc23a211
TD Cowen Raises Boston Scientific's Price Target to $77 From $65, Maintains Outperform Rating MT
ANALYST RECOMMENDATIONS : Block, Quanta Services, Nvidia, Home Depot, Nutrien... Our Logo
Raymond James Adjusts Price Target on Boston Scientific to $73 From $67, Maintains Strong Buy Rating MT
Jefferies Adjusts Price Target on Boston Scientific to $74 From $62, Maintains Buy Rating MT
JPMorgan Chase Adjusts Price Target on Boston Scientific to $72 From $60, Maintains Overweight Rating MT
Mizuho Securities Upgrades Boston Scientific to Buy From Neutral, Raises Price Target to $80 From $65 MT
Wells Fargo Raises Price Target on Boston Scientific to $72 From $70, Maintains Overweight Rating MT
Truist Securities Raises Price Target on Boston Scientific to $73 From $70, Keeps Buy Rating MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $81 From $77, Keeps Buy Rating MT
Needham Adjusts Boston Scientific's Price Target to $71 From $60, Keeps Buy Rating MT
Oppenheimer Raises Boston Scientific Price Target to $68 From $58, Maintains Perform Rating MT
RBC Lifts Price Target on Boston Scientific to $70 From $67 Amid 'Solid Q4 Beat,' Says 2024 Guidance Looks Conservative, Keeps Outperform Rating MT
Which Jerome will we get? Our Logo
UBS Adjusts Boston Scientific Price Target to $71 From $67, Maintains Buy Rating MT
RBC Lifts Price Target on Boston Scientific to $67 From $61, Cites Stock Runup, Growth Opportunities Amid Axonics Deal, Outperform Kept MT
Investors lower their expectations Our Logo
Raymond James Adjusts Price Target on Boston Scientific to $67 From $61, Maintains Strong Buy Rating MT
Truist Securities Increases Price Target on Boston Scientific to $66 From $59, Maintains Buy Rating MT
Wells Fargo Raises Price Target on Boston Scientific to $62 From $59, Keeps Overweight Rating MT
TD Cowen Adjusts Price Target on Boston Scientific to $65 From $58, Maintains Outperform Rating MT
Morgan Stanley Adjusts Price Target on Boston Scientific to $61 From $58, Maintains Overweight Rating MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $64 From $60, Maintains Buy Rating MT
UBS Raises Boston Scientific Price Target to $67 From $66, Maintains Buy Rating MT
Oppenheimer Adjusts Boston Scientific Price Target to $58 From $59, Maintains Perform Rating MT
Needham Adjusts Price Target on Boston Scientific to $60 From $65, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
67.24 USD
Average target price
71.47 USD
Spread / Average Target
+6.30%
High Price Target
81 USD
Spread / Highest target
+20.46%
Low Price Target
55 USD
Spread / Lowest Target
-18.20%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Boston Scientific Corporation

TD Cowen
Raymond James
Jefferies & Co.
JPMorgan Chase
Mizuho Securities
Wells Fargo Securities
Canaccord Genuity
Truist Securities
Needham & Co.
Oppenheimer
RBC Capital Markets
UBS
Morgan Stanley
Stifel Nicolaus
Baird
Bernstein
BTIG
Barclays
Evercore ISI
Piper Sandler
CL King
Citigroup
Deutsche Bank Securities
Goldman Sachs
Wolfe Research
BofA Securities
SVB Leerink
Credit Suisse
Argus
Atlantic Equities
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
  1. Stock
  2. Equities
  3. Stock Boston Scientific Corporation - Nyse
  4. Consensus Boston Scientific Corporation